- Home
- KRNY vs TERN Comparison
KRNY vs TERN Comparison
Compare KRNY & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRNY
- TERN
- Stock Information
- Founded
- KRNY 1884
- TERN 2017
- Country
- KRNY United States
- TERN United States
- Employees
- KRNY N/A
- TERN N/A
- Industry
- KRNY Savings Institutions
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- KRNY Finance
- TERN Health Care
- Exchange
- KRNY Nasdaq
- TERN Nasdaq
- Market Cap
- KRNY 436.9M
- TERN 382.2M
- IPO Year
- KRNY 2005
- TERN 2021
- Fundamental
- Price
- KRNY $7.32
- TERN $4.45
- Analyst Decision
- KRNY Buy
- TERN Buy
- Analyst Count
- KRNY 2
- TERN 5
- Target Price
- KRNY $7.75
- TERN $18.30
- AVG Volume (30 Days)
- KRNY 349.4K
- TERN 1.8M
- Earning Date
- KRNY 01-30-2025
- TERN 03-13-2025
- Dividend Yield
- KRNY 6.09%
- TERN N/A
- EPS Growth
- KRNY N/A
- TERN N/A
- EPS
- KRNY N/A
- TERN N/A
- Revenue
- KRNY $128,413,999.00
- TERN N/A
- Revenue This Year
- KRNY N/A
- TERN N/A
- Revenue Next Year
- KRNY $28.55
- TERN N/A
- P/E Ratio
- KRNY N/A
- TERN N/A
- Revenue Growth
- KRNY N/A
- TERN N/A
- 52 Week Low
- KRNY $5.28
- TERN $4.32
- 52 Week High
- KRNY $8.59
- TERN $11.40
- Technical
- Relative Strength Index (RSI)
- KRNY 50.99
- TERN 27.09
- Support Level
- KRNY $7.10
- TERN $4.38
- Resistance Level
- KRNY $7.36
- TERN $5.95
- Average True Range (ATR)
- KRNY 0.24
- TERN 0.29
- MACD
- KRNY 0.06
- TERN -0.09
- Stochastic Oscillator
- KRNY 90.59
- TERN 4.46
About KRNY Kearny Financial Corp
Kearny Financial Corp is a federally-chartered stock savings bank. The bank is engaged in the business of attracting deposits from the general public in New Jersey and New York, and using these deposits, together with other funds, to originate or purchase loans for its portfolios and invest in securities. The bank's loan portfolio is chiefly comprised of loans collateralized by commercial and residential real estate. It is also heavily into secured and unsecured business and consumer loans. The bank's primary source of income is net interest income.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.